Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stoker, Thomas B."'
Autor:
Stoker TB; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK tbs26@cantab.net., Mason SL; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Greenland JC; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Holden ST; Department of Clinical Genetics, Addenbrooke's Hospital, Cambridge, UK., Santini H; Huntington Disease Association, Liverpool, UK., Barker RA; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Wellcome Trust Medical Research Council - Cambridge Stem Cell Institute, Cambridge, UK.
Publikováno v:
Practical neurology [Pract Neurol] 2022 Feb; Vol. 22 (1), pp. 32-41. Date of Electronic Publication: 2021 Aug 19.
Autor:
Stoker TB; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. tbs26@cantab.net., Holden ST; Department of Clinical Genetics, East Anglian Medical Genetics Service, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Barker RA; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.; Wellcome Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Publikováno v:
Journal of neurology [J Neurol] 2021 Oct; Vol. 268 (10), pp. 3916-3919. Date of Electronic Publication: 2021 Jun 17.
Autor:
Stoker TB; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Andresen KER; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Barker RA; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 Jan; Vol. 36 (1), pp. 263-264. Date of Electronic Publication: 2020 Oct 30.
Autor:
Stoker, Thomas B, Mason, Sarah L, Greenland, Julia C, Holden, Simon T, Santini, Helen, Barker, Roger A
Huntington's disease (HD) is an inherited neurodegenerative disease characterised by neuropsychiatric symptoms, a movement disorder (most commonly choreiform) and progressive cognitive impairment. The diagnosis is usually confirmed through identifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de517f186e3013d31250042fb2eb59cf
https://www.repository.cam.ac.uk/handle/1810/325160
https://www.repository.cam.ac.uk/handle/1810/325160
Huntington’s disease (HD) is an autosomal dominant neurodegenerative condition caused by trinucleotide CAG repeat expansion in the huntingtin gene. CAG lengths of more than 35 repeats are associated with disease, whilst CAG lengths of less than 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4c03639c9b0f25e9c2c6873bc04fc2
https://www.repository.cam.ac.uk/handle/1810/323650
https://www.repository.cam.ac.uk/handle/1810/323650
Publikováno v:
Journal of Neurology; Oct2021, Vol. 268 Issue 10, p3920-3920, 1p
Publikováno v:
Movement Disorders
Huntington’s disease (HD) is a genetic disorder caused by an expanded CAG repeat in the huntingtin gene, and although there are currently no disease-modifying treatments, there is much excitement about the prospect of treatments targeting huntingti